(19)
(11) EP 0 936 924 A2

(12)

(43) Date of publication:
25.08.1999 Bulletin 1999/34

(21) Application number: 97918947.0

(22) Date of filing: 22.07.1997
(51) International Patent Classification (IPC): 
A61K 45/ 00( . )
A61K 31/ 44( . )
A61K 31/ 445( . )
A61K 45/ 06( . )
A61K 31/ 435( . )
A61K 31/ 4439( . )
A61K 31/ 55( . )
A61P 25/ 18( . )
(86) International application number:
PCT/EP1997/004159
(87) International publication number:
WO 1998/004289 (05.02.1998 Gazette 1998/05)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
SI

(30) Priority: 26.07.1996 GB 19960015767

(71) Applicant: SMITHKLINE BEECHAM PLC
Brentford, Middlesex TW8 9EP (GB)

(72) Inventor:
  • BLACKBURN, Thomas Paul, SmithKline Beecham
    Third Avenue Harlow Essex CM19 5AW (GB)

(74) Representative: Waters, David Martin, Dr., et al 
Smithkline Beecham plc Corporate Intellectual Property, Two New Horizons Court
Brentford, Middlesex TW8 9EP
Brentford, Middlesex TW8 9EP (GB)

   


(54) PHARMACEUTICAL COMPOSITION CONTAINING A 5HT 2C? ANTAGONIST AND A D 2? ANTAGONIST